Trademark Alertz ®
Search
Trademark
Owner
Trademark: SYNKLINO 2362804
Word
SYNKLINO
ID
2362804
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
06 January 2023
Registration Date
06 January 2023
Renewal Date
06 January 2033
Owner(s)
SYNKLINO A/S
Service
SHELLEY EINFELD IP PTY LTD
Goods and Services:
Class 5
:
Pharmaceutical preparations
;
pharmaceutical preparations for regulating the immune system
;
pharmaceutical preparations for use in organ transplantation
;
pharmaceutical preparations for the prevention of diseases of the immune system
;
immunosuppressants for use following transplantation in the case of graft rejection
;
pharmaceutical preparations for the treatment of immune system related diseases and disorders
;
immunotherapeutic agents for bacterial infections
;
pharmaceutical preparations for immunity adjustment
;
pharmaceutical preparations containing stem cells
;
immunoassay reagents for medical use
;
pharmaceutical preparations for the treatment of viral diseases
;
anti-viral agents
;
protein synthesis inhibitors
;
regulatory proteins being pharmaceutical preparations for medical use
;
pharmaceutical drugs
;
antibacterial pharmaceuticals.
Class 10
:
Surgical apparatus and instruments for medical use
;
diagnostic test instruments for use in immunoanalytical procedures [medical]
;
diagnostic testing apparatus for use in medical immunoassay procedures
;
devices for regenerating stem cells for medical purposes
;
apparatus for medical cell sampling
;
pharmaceutical instruments.
Class 42
:
Scientific research
;
scientific services
;
research into stem cells
;
culturing of cells for scientific research purposes
;
services relating to research and development in the field of immunology
;
pharmaceutical research
;
development of pharmaceutical preparations
;
pharmaceutical research and development services
;
development of pharmaceutical preparations and medications
;
carrying out clinical trials for pharmaceutical products
;
laboratory research on pharmaceutical preparations
;
consultancy regarding drug research and development
;
software as a service [SaaS].